Carrick Therapeutics Stock

Carrick Therapeutics is a developer of cancer therapeutics intended to transform the way cancer is treated.

Sign up today and learn more about Carrick Therapeutics Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Carrick Therapeutics Stock

Carrick Therapeutics is a developer of cancer therapeutics intended to transform the way cancer is treated. The company's therapeutics target molecular pathways that drive the most aggressive and resistant forms of cancer using innovative mechanisms, enabling cancer patients to get their predictive biomarkers detected and get their treatments started from early stage.

Funding History

October 2016$95.0M
December 2022$60.0M

Management

CEO

Timothy Pearson

SVP of Business Development

Jenny Horsfield

Non Executive Director

Jonathan Hepple

Head of Research and Development

Ashwani Bahl

Board of Directors

Paul Thurk

Head of Discovery

Edward Ainscow

VP Business Development & Alliance Management

Anthony Brown

Board of Directors

Jason Lettmann

Advisory Board

Adam Schayowitz

Chief Medical Officer

Stuart McIntosh

Vice President of CMC Manufacturing

Paul McGee

Board of Directors

Steven Gillis

Press

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Logo